LOS ANGELES (PRWEB)
December 08, 2021

Seraphina Therapeutics, with its patented dietary supplement fatty15 and ingredient FA15TM, was recognized by Nutritional Outlook Magazine as 2021 Best of the Industry Award winner. Seraphina was chosen for this award for its groundbreaking work in C15:0 and for being a company that “has not only taken on the mantle of bringing a completely novel nutrient to the market but [has] a larger ambition of correcting a major nutrient deficiency.”

The Best of the Industry Award is chosen by Nutritional Outlook’s editors, with input from the editorial advisory board, who recognize companies whose trailblazing achievements are helping to shape, for the better, the state of the dietary supplement and natural products industry. Each year, only four leaders are chosen in different categories. In its feature article on Seraphina Therapeutics and fatty15, Sebastian Krawiec at Nutritional Outlook shared that Seraphina is poised to become a leader in developing scientifically substantiated nutritional solutions, especially as the body of research on C15:0’s health benefits continues to grow.

Seraphina Therapeutics launched fatty15 during January 2021, which sold out in 6 weeks and has maintained a consistently high monthly customer retention rate of greater than 90%. The company is the first to discover C15:0 as essential fatty acid and to bring its pure and vegan-friendly C15:0 powder ingredient (called FA15TM) to the world via fatty15. FA15TM acquired GRAS status earlier this year, and a randomized, double-blinded, and placebo-controlled clinical trial to evaluate the physiological benefits of fatty15 is underway at the University of California, San Diego.

A growing body of science supports C15:0 as the first essential fatty acid to be discovered in 90 years, which means that C15:0 is required by our bodies to maintain our health, especially with age. In large prospective population studies, higher dietary and body levels of C15:0 have been linked to living longer, as well as improved heart, metabolic, and liver health. As published in Nature’s Scientific Reports, the pure powder C15:0 ingredient in fatty15 has been shown to improve cellular health and reverse key hallmarks of aging, primarily by targeting key receptors (called PPAR ɑ/δ) that regulate metabolism, immunity, mood, sleep, and appetite, as well as strengthening cell membranes and repairing mitochondria. In these studies, daily supplementation with C15:0 resulted in improved cholesterol, glucose, immune, red blood cell, and liver health in vivo.

Seraphina Therapeutics, with its fatty15 supplement and FA15TM ingredient, is continuing to lead research on C15:0 and other nutrients critical to ensuring healthy aging at the cellular level. This industry award is a key milestone for Seraphina, which has raised $13.2M in Series A financing to expand the science, awareness, and commercial growth of fatty15 and FA15TM during 2022.

About Seraphina Therapeutics

Seraphina Therapeutics is a team of doctors, scientists, and innovators who work hard every day to help people age smarter and healthier. We’ve spent over 15 years working on a big discovery that fits in one tiny pill—C15:0 (FA15TM), the first essential fatty acid to be found in 90 years. Fatty15 is our breakthrough, patented, and award-winning pure C15:0 supplement that enables a reset on healthy aging at the cellular level, resulting in benefits that can be felt within weeks and seen within months.

Share article on social media or email:

These new additions to the Eagle executive leadership team will help round-out our executive bench as well as better position us during this pivotal stage of our growth.

ATLANTA (PRWEB)
December 08, 2021

Eagle Telemedicine, a pioneer in inpatient telemedicine, today announced the expansion of its executive leadership and operations team in preparation for rapid growth in 2022. In Q4, Eagle expanded its C-suite with three new executive hires including Matthew Goggin, Senior Vice President of Marketing; Michael Byman, Vice President of Sales; and Jeff Adams, Vice President of Information Technology.

“We’ve been hiring steadily over the past year but in Q4 we made a number of key investments in our executive leadership as well as making investments in operations,” stated Jason Povio, President and Chief Operating Officer, Eagle Telemedicine. “These new additions to the Eagle executive leadership team will help round-out our executive bench as well as better position us during this pivotal stage of our growth.”

Goggin comes to Eagle with over 30 years of enterprise-level marketing experience in the tech industry and sat on a number of Marketing Advisory Boards including HP, Dell, Commvault and TrendMicro. As Eagle’s marketing leader, Goggin’s priorities will include working seamlessly with business development, expanding on Eagle’s brand awareness as well as continue to increase its thought-leadership positioning in the industry. Other marketing endeavors will include enhanced short-form videos, heightened influencer marketing and continued investment in online events.

Byman is a seasoned sales leader with experience at Jackson Healthcare, Merritt Hawkins and Gain Servicing. He is also a frequent speaker and authority on medical staffing trends and healthcare reform. As the head of Eagle’s sales team, Byman plans on continuing to lead the industry through insight and innovation, providing hospitals with the best solutions and tools to optimize patient outcomes. Byman is also expanding the business development team in 2022 to gain additional market share in all 50 states as well as adding new telemedicine specialties to meet market demand.

Adams brings more than 25 years of healthcare IT, management consulting and leadership to the organization. As Vice President of Information Technology, he will lead efforts to improve the company’s technology portfolio and drive efficiencies using technology for the betterment of telehealth. His experience working with both urban and rural health systems throughout the country also allows Adams to assist Eagle customers with the latest telemedicine technology innovations.

Eagle additionally made material investments in the quarter to expand its operations teams. These investments include new technology-enabled business automation tools which are the backbone of improved workflows to support the critical work of Eagle’s teams that implement and support clinical programs. In addition to these technology investments, Eagle has also invested in human talent in key functional roles. These talented individuals will work to provide Eagle’s clients with the trusted partnership they expect when engaging to support the care of their patients and communities.    

The telemedicine market is poised for rapid growth with Allied Market Research projecting it to reach $431.82 billion by 2030 (with a CAGR of 25.9%). Eagle is uniquely positioned to meet this demand head on, providing the needed access to specialists for hospitals to better care for patients and communities across the country.

“We’re excited about all the investments we’re making across the board from sales and marketing to operations,” added Povio. “2022 will be a momentous year for Eagle with a number of landmark milestones. We are seeing an exploding market opportunity for telemedicine and with the addition of Matthew, Michael and Jeff to our leadership team we have the expertise to fuel our growth while helping hospitals across the country better serve their patients.”    

Goggin, Byman and Adams have joined Eagle effective December 1. All report directly to Povio.

About Eagle Telemedicine

Eagle Telemedicine provides technology-enabled care. Eagle was one of the first companies to emerge in the telemedicine physician service arena and is still pioneering the industry a decade later. It designs, manages and operates telemedicine programs for acute care hospitals, critical access hospitals and long-term acute care hospitals. Eagle’s solutions help facilities offer specialized care to underserved communities, eliminate locum support costs, prevent burnout, manage coverage gaps, reduce unnecessary transfers, and increase patient census. Multiple specialties include Hospitalist Medicine, Stroke and Acute Neurology, Psychiatry, Critical Care, Cardiology, Infectious Disease and a range of other specialties in a wide variety of service models. For more information, visit http://www.eagletelemedicine.com or follow us on LinkedIn at https://www.linkedin.com/company/eagle-telemedicine.

Share article on social media or email:

“We see patients hopeful again, knowing they no longer need to settle with managing chronic disease over their lifetime, but restoring their health beyond their imagination.”

ST. LOUIS (PRWEB)
December 08, 2021

The American College of Lifestyle Medicine (ACLM) has announced the addition of Canadian multi-specialty healthcare leader Aroga Lifestyle Medicine to its Corporate Roundtable, a group of thought leaders and industry professionals who explore effective clinical innovations, activate marketing strategies, accelerate reimbursement and policy adoption, and pursue research and demonstrations of lifestyle medicine in practice. ACLM launched its Corporate Roundtable in 2016 and now includes more than 40 active member organizations in the lifestyle medicine ecosystem.

Lifestyle medicine is defined as the use of evidence-based lifestyle therapeutic intervention—including a whole-food, plant-predominant eating pattern, regular physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connection—as a primary modality, delivered by clinicians trained and certified in this specialty, to prevent, treat, and often reverse chronic disease.

Aroga is a collaborative, patient-centered lifestyle medicine healthcare organization serving     patients in British Columbia and Ontario and quickly expanding across the country. Its core team includes specialists in internal medicine, endocrinology, bariatrics, pediatrics, psychiatry, psychotherapy, sleep medicine and family medicine, along with allied healthcare professionals and health coaches.

“There is an inherent synergy throughout the ACLM and its Corporate Roundtable members, grounded in the understanding that the current status quo healthcare system needs to change,” said Aroga CEO Amar Magon. “We see the results of our approach, combined with evidence-based research, daily. We see patients hopeful again, knowing they no longer need to settle with managing chronic disease over their lifetime, but rather making a right-about-turn and restoring their health beyond their imagination. We humbly welcome the opportunity to learn from and share knowledge with Roundtable members and work collectively to make our shared visions of healthcare a reality.”

Aroga’s foundation is firmly built on the bedrock of lifestyle medicine and is reflected in its mission, clinical practices, and patient services. Based on the principle that every human, given the right tools, support and knowledge, can be empowered to optimize their health and happiness, Aroga’s mission is to truly heal individuals, families, and communities. Its approach has inspired patients and practitioners alike as Aroga continues to grow and expand its message and delivery model across Canada.

“Aroga has a vision for reimagining healthcare where actual healing rather than managing chronic disease is the goal,” said ACLM President Cate Collings, MD, MS, FACC, DipABLM. “They understand that combining nourishing plant-based food, restful sleep, physical activity, avoiding substance use, mindfulness, and meaningful, nurturing connections can be radically transformative and empowering. We congratulate them on their efforts to make a difference and we welcome them to the Corporate Roundtable.”

ABOUT AROGA HEALTH: Aroga is Canada’s leading lifestyle medicine healthcare organization. Founded in 2017, Aroga has established its care delivery model in British Columbia and Ontario, serving     patients and supporting them to reclaim their lives. Embedded in lifestyle medicine, its healthcare model offers patient-centered, evidence-based treatments to help patients prevent, treat and reverse chronic diseases. In the ancient language of Sanskrit, the word “roga” means disease. The “a” prefix transforms the word to be without disease. Together, “Aroga” means total well-being consisting of a healthy mind, body, heart and soul, the organization’s vision for healthcare.

ABOUT THE AMERICAN COLLEGE OF LIFESTYLE MEDICINE: ACLM is the medical professional society for those dedicated to the advancement and clinical practice of lifestyle medicine as the foundation of a transformed and sustainable health care system. Lifestyle medicine is the use of evidence-based lifestyle therapeutic intervention—including a whole-food, plant-predominant eating pattern, regular physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connection—as a primary modality, delivered by clinicians trained and certified in this specialty, to prevent, treat, and often reverse chronic disease.

More than a professional association, ACLM is a galvanized force for change. ACLM addresses the need for quality education and certification, supporting its members in their individual practices and in their collective mission to domestically and globally promote lifestyle medicine as the first treatment option, as opposed to a first option of treating symptoms and consequences with expensive, ever-increasing quantities of pills and procedures.

https://www.lifestylemedicine.org

Share article on social media or email:

Laguna Sunscreen – Everyday Inspired

The goal is to provide all travelers and resort guests the same amazing SUNPLUS experience that our loyal customers have grown to love.

LAGUNA BEACH, Calif. (PRWEB)
December 08, 2021

SUNPLUS announced it was recently selected to provide sunscreen to pool, beach, spa, and resort guests at the upscale Montage Resort in Laguna Beach, California. The high-performance sunscreen is loaded with skin beneficial and moisturizing ingredients. The contract is in keeping with the young startup’s expansion plans into resorts worldwide and its growing customer base of retailers, boutiques, markets, spas, pharmacies, estheticians, fitness and yoga studios, and more.

The resort saw value in providing its guests a premium product from a local company that meets Montage’s guest experience expectations. Guests will appreciate the performance, skin benefits, and silky smooth and luxurious feel on their skin.

“We were awarded this opportunity over other leading resort sunscreen brands, which is a major win for our growing company, helping to exceed our expectations in our first year,” said Scott Mehler, CEO and founder of SUNPLUS. “This new prestige account on top of our great ongoing sales at the luxury Terranea Resort and other Southern California resorts and retailers will help us move into more resorts worldwide. The goal is to provide all travelers and resort guests the same amazing SUNPLUS experience that our loyal customers have grown to love.”

Having five or more sunburns doubles the risk for melanoma, with one in five Americans having skin cancer by the time they turn 70. Unprotected sun exposure also leads to premature aging and other skin damage and irritation. SUNPLUS protects from the sun’s harmful rays while moisturizing, soothing and guarding skin against pollutants and premature aging. The sunscreen does not sting eyes and is gentle on sensitive skin while being water-resistant and sweat-proof.

The SUNPLUS collection consists of everyday, sport, ocean, and family-inspired sunscreens, all with a combination of vitamins, rich and multi-level moisturizers, antioxidants and skin-loving superfoods. Ingredients include rich botanicals and fruits like sunflower, chamomile, evening primrose, and red raspberry seeds. These thoughtful ingredients are what set SUNPLUS apart; making it not only a high performance sunscreen, but a luxurious moisturizer too, leaving the skin feeling and looking better after a day in the sun.

Kind to the skin and the planet, the packaging is plant-based and ingredients are biodegradable, safe for sensitive skin, and ocean and reef safe. The brand gives back to organizations that preserve the ocean and natural environments.

For more information, visit https://www.sunplusca.com.

About SUNPLUS: Based in Southern California, SUNPLUS was developed from a love for living a balanced, wellness-focused, outdoor lifestyle. The eco-friendly brand creates ultra-effective, performance-rich, healthy sun care products designed to enhance lifestyles under the sun. SUNPLUS products combine the best features of a high-performance sunscreen and an ultra skin beneficial moisturizer, leaving your skin protected and feeling and looking better after a day in the sun.

Share article on social media or email:

Understanding how the brain works and harnessing neurofeedback to train ourselves for peak performance is empowering, and Sens.ai makes it accessible to anyone. Our growing network of backers has been a clear confirmation that Sens.ai is a product people need and want to help fuel their lives.

WHISTLER, British Columbia (PRWEB)
December 08, 2021

Today, Sens.ai announces it has surpassed $650,000 USD in crowdfunding on Indiegogo. The campaign officially ends on December 30, 2021, but already has the support of more than 680 backers.

People are looking for a way to achieve a competitive advantage. Meditation apps, training programs, and life and business coaches are all tools employed by many to help them increase performance in a variety of ways. From work to sports to artistic pursuits, calming the brain and training it to achieve peak performance can be difficult to master.

Sens.ai is a consumer brain training solution in a headset that combines with an app to provide more than 20 training programs to help users achieve their goals.

The headset features comfortable, all-day wear EEG electrodes, a high signal quality EEG for clinical-grade neurofeedback, specialized LEDs for light therapy, a heart-rate monitor, Bluetooth sound connectivity to smartphones and tablets, and an audio-in jack.

“Sens.ai is exciting because it’s the first-ever personalized neuroadaptive system,” says Dr. Drew Pierson, former Head of Neuroscience, 40 Years of Zen. “This means it allows you to train your brain, your heart, and receive light in the form of photobiomodulation while it adapts to your own personal neural output. It’s an integration of multiple clinical-grade systems into a scalable wearable. Imagine the impact to humanity of bringing this quality of neurotech to homes around the world.”

Sens.ai takes decades of clinical research and applies it in a consumer setting. Combining neurofeedback, which has long been used in Neurotherapy clinics for recovery and performance with photobiomodulation and heart rate variability training, Sens.ai is a powerful tool that‘s simple to use.

“The most intriguing frontier for exploration isn’t the depths of the universe, but the exploration of our own inner space,” said Paola Telfer, CEO and Founder Sens.ai. “Understanding how the brain works and harnessing neurofeedback to train ourselves for peak performance is empowering, and Sens.ai makes it accessible to anyone. Our growing network of backers has been a clear confirmation that Sens.ai is a product people need and want to help fuel their lives.”

Sens.ai features three use modes: Boost, Train and Assess. Boost provides non-invasive light stimulation to prime the brain for any state or activity. Gamma boost provides energy and sharpness. Alpha boost provides a calm, creative flow, and Theta boost is akin to a float-tank experience without the tank.

Sens.ai’s “Train mode” is the first wearable technology to train multiple brainwaves essential for peak performance. It combines audio and visual neurofeedback with integrated heart rate variability training and light stimulation for faster, holistic results. Users can select 20-minute, a-la-carte programs or enjoy them as part of a larger Mission. Missions are built-in multi-week expert-designed courses. ​​Programs are healthy mind states mapped to brain frequencies and locations. Assess mode provides functional testing of a user’s cognitive enhancement beyond mere reporting of data.

“Sens.ai is the Neurowearable I have been waiting for, both for myself and my clients,” says Dr. Amy Serin, Neuropsychology Ph.D., and owner of Serin Centers. ”With superb engineering, they have combined the best in-clinic methods we have been using for decades into 1 device, that both personalizes to your goals and adapts to your biometrics in real-time. Combining transcranial photobiomodulation with Neurofeedback was brilliant in that it gives consumers the best of both worlds – an immediately felt state change and the long-term trait changes we all ultimately want.”

With Sens.ai, people can supercharge their brains for calm, focused performance in as little as 20 minutes, three times a week. Sens.ai is available to pre-order before December 30 by visiting https://www.indiegogo.com/projects/sens-ai-make-your-brain-sharper-faster-better#.

About Sens.ai

Sens.ai is a Canadian neurotech start-up founded in 2018. Sens.ai believes that changing the world starts with changing oneself. They endeavor to empower people to accelerate their personal development with leading-edge neurotechnology. The team has carefully constructed Programs that can accompany each person on a journey to peak performance and awakening. They have integrated a seamless user experience with science-based personalization to yield quantified progression that’s trackable.

For more information, visit https://sens.ai/.

Share article on social media or email:

Alucio

“We are really excited to be releasing these additional personalization features for our users to enable them to be even more effective in their engagements with KOLs and other audiences,” says Dave Gulezian, Alucio Co-Founder & CEO.

SAN FRANCISCO (PRWEB)
December 08, 2021

Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, announced new personalization enhancements to its flagship product, Beacon. Beacon is a modern content activation and HCP engagement platform built specifically for medical science liaisons (MSLs), medical affairs and market access professionals.

These enhanced product features include a new, updated version of Beacon’s presentation builder. This interactive tool enables users to create and save custom presentations, subject to medical and regulatory constraints, through an intuitive interface. As a result, users are able to tailor their presentation content to match the specific information needs of their audiences while remaining fully compliant with industry and company guidelines.

With this update, Alucio has further streamlined and simplified the workflow to make it even easier for users to assemble content and build custom presentations. Additionally, customers now have the option to allow their field users to upload and insert their own company-approved content as part of the build process including personalized introductory material.

Beacon’s robust version control features also ensure that users are effectively notified of any changes to source content that may impact their custom presentations. Moreover, all Beacon’s presentation builder capabilities are present across both the desktop and tablet instances of the platform.

In addition to Beacon’s presentation builder updates, field users and content publishers can now share their favorite content folders on Beacon with other team members. These shared folders may contain various medical and scientific materials including disease state information, clinical trial results, standard response letters, training content and congress-related information.

“We are really excited to be releasing these additional personalization features for our users to enable them to be even more effective in their engagements with KOLs and other audiences,” says Dave Gulezian, Alucio Co-Founder & CEO. “Our Beacon platform can be a highly effective tool in helping life science companies become more KOL-centric in their scientific exchange efforts.”

Jane Varian, a senior field medical director and Alucio product advisory board member, shared her perspectives. “It is incredibly important to be able to tailor presentations to meet the specific information needs of individual KOLs. Beacon allows for simple and effective content customization that advances scientific exchange while ensuring that compliance requirements are met.”

To learn more about Beacon and to schedule a product demonstration, please contact the company at sales@alucio.io.

About Alucio:

Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at lamin@alucio.io (925) 788-3533.

Share article on social media or email: